Clinical Trial Update: Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease [Phase 3]

View source ↗

Summary

A Phase III trial compared Zegerid with Losec for relief of heartburn in gastroesophageal reflux disease, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• LOSEC
• Zegerid (omeprazole/sodium bicarbonate)

Snippet

Sponsor: Norgine | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED | Results posted: 2013-08-13